| 名稱 | AI-Edigene® FGFR3(E17)-TACC3(E10) Fusion |
| 型號 | CBP20200R |
| 報價 |  |
| 特點 | AI-Edigene® FGFR3(E17)-TACC3(E10) Fusion |
產品搜索
相關文章
聯系我們
產品展示 / PRODUCTS
- 詳細內容
CBP20200R | |
| Format | RNA |
| Description | FGFR3-TACC3 results from the fusion of FGFR3 and TACC3, demonstrating constitutive kinase activity, transforming activity in culture and ability to drive tumor growth in xenografts (PMID: 25294908, PMID: 22837387). FGFR3-TACC3 has been identified in lung adenocarcinoma and glioblastoma (PMID: 25294908, PMID: 22837387). |
| Technical Data | |
| Left Gene | FGFR3 |
| Left Breakpoint | chr4:1808661:+ |
| Right Gene | TACC3 |
| Right Breakpoint | chr4:1739325:+ |
| Cosmic ID | COSF1434 |
| Buffer | RNase-free H2O |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| RNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | -80℃ |
| Expiry | 12 months from the date of manufacture |
